Marwan Hariz, MD, PhD and Jordan P. Amadio, MD, MBA
Deep brain stimulation (DBS) for enhancements of non-disease states is ethically indefensible given our incomplete knowledge of this technology. Attention should instead be focused on increasing access to DBS for patients with illnesses potentially treatable by the procedure.
Concerns about the deleterious effects of stress on the mind and body have led to the beginnings of a stress vaccine, an injection that will reduce these effects.
Lusine Aghajanova, MD, PhD and Cecilia T. Valdes, MD
While sex selection of children for nonmedical reasons is not prohibited in the United States, the authors believe that sperm sorting should not be used until more safety data are available.
The author argues that long-term trends point to a future for physician assistants and nurse practitioners as the principal front-line deliverers of primary care, with physicians focusing on managerial duties and specialty care.
David Elkin, MD, Erick Hung, MD, and Gilbert Villela, MD
The rapidly evolving field of neuroethics is concerned with the ethical questions that new technologies will pose about autonomy, privacy, the definition of normal, and individuality.
While critics of section 6001 of the ACA warn that it will debilitate an important competitive force in the marketplace, it does not categorically eliminate further development of the physician-owned hospital industry.
This month theme issue editor, Trahern Jones, a fourth-year student at Mayo Medical School in Rochester, Minnesota, spoke with Dr. Edward Laskowski about the use of performance-enhancing drugs and substances among athletes today.